Delivery Order SPE2DB20D2014-SPE2DB24FB05S

Award Date 2/12/24
Potential Completion Date 3/5/24
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $38,880.90, is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The award has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger indefinite delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of March 26, 2024 and a potential value of $12,345.34. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,960.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a potential value of $24,690.70 and a completion date of March 12, 2024. Amerisourcebergen Drug Corporation serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The potential value of the contract is $12,345.34, with a completion date of January 18, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has a history of providing...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $13,846.97 and a performance period through May 9, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $12,960.30, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a potential value of $24,690.70 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This award is not associated with any set-aside designation....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $38,880.90 contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor on a $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $24,690.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB05S
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a potential value of $49,381.36 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is not operating under any set-aside designation. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/13/24, 9:25 AM